Susquehanna International Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-57,800
Closed -$215K 13713
2024
Q4
$215K Sell
57,800
-57,600
-50% -$266K ﹤0.01% 10576
2024
Q3
$645K Buy
115,400
+400
+0.3% +$2.8K ﹤0.01% 7863
2024
Q2
$968K Buy
115,000
+85,200
+286% +$908K ﹤0.01% 6672
2024
Q1
$430K Sell
29,800
-109,900
-79% -$1.82M ﹤0.01% 8874
2023
Q4
$3.01M Buy
139,700
+101,700
+268% +$1.81M ﹤0.01% 4573
2023
Q3
$730K Sell
38,000
-23,100
-38% -$493K ﹤0.01% 7357
2023
Q2
$1.55M Buy
61,100
+37,200
+156% +$1.07M ﹤0.01% 5687
2023
Q1
$864K Buy
23,900
+18,400
+335% +$646K ﹤0.01% 7204
2022
Q4
$218K Sell
5,500
-16,700
-75% -$694K ﹤0.01% 9915
2022
Q3
$1.03M Buy
+22,200
New +$1.03M ﹤0.01% 6558
2022
Q2
Sell
-14,800
Closed -$1.07M 14155
2022
Q1
$1.07M Sell
14,800
-5,600
-27% -$404K ﹤0.01% 6945
2021
Q4
$1.65M Sell
20,400
-10,900
-35% -$1.09M ﹤0.01% 5971
2021
Q3
$3.64M Buy
31,300
+2,200
+8% +$288K ﹤0.01% 4555
2021
Q2
$4.82M Buy
29,100
+14,000
+93% +$2.19M ﹤0.01% 4100
2021
Q1
$2.11M Sell
15,100
-8,600
-36% -$1.4M ﹤0.01% 5805
2020
Q4
$4.1M Sell
23,700
-25,600
-52% -$4.15M ﹤0.01% 3762
2020
Q3
$6.87M Sell
49,300
-39,800
-45% -$5.32M ﹤0.01% 2672
2020
Q2
$10.6M Sell
89,100
-17,200
-16% -$2.04M ﹤0.01% 2058
2020
Q1
$10.6M Buy
106,300
+2,900
+3% +$349K ﹤0.01% 1673
2019
Q4
$12.2M Sell
103,400
-66,100
-39% -$6.55M ﹤0.01% 1881
2019
Q3
$14.6M Buy
169,500
+34,400
+25% +$2.6M ﹤0.01% 1601
2019
Q2
$8.76M Buy
135,100
+72,300
+115% +$4.5M ﹤0.01% 2019
2019
Q1
$3.93M Sell
62,800
-154,000
-71% -$7.24M ﹤0.01% 2746
2018
Q4
$8.43M Buy
216,800
+134,700
+164% +$5.99M ﹤0.01% 1768
2018
Q3
$4.68M Buy
82,100
+54,200
+194% +$3.39M ﹤0.01% 2777
2018
Q2
$2.23M Buy
27,900
+21,200
+316% +$1.76M ﹤0.01% 3831
2018
Q1
$581K Sell
6,700
-22,400
-77% -$1.81M ﹤0.01% 6326
2017
Q4
$2.01M Sell
29,100
-55,700
-66% -$4.46M ﹤0.01% 3910
2017
Q3
$7.71M Sell
84,800
-37,400
-31% -$3.2M ﹤0.01% 2026
2017
Q2
$9.1M Buy
122,200
+79,400
+186% +$6.36M ﹤0.01% 1777
2017
Q1
$4.01M Sell
42,800
-27,600
-39% -$2.5M ﹤0.01% 2609
2016
Q4
$5.12M Buy
70,400
+13,100
+23% +$1.12M ﹤0.01% 2406
2016
Q3
$5.98M Sell
57,300
-65,500
-53% -$5.92M ﹤0.01% 2037
2016
Q2
$9.06M Buy
122,800
+89,100
+264% +$6.05M ﹤0.01% 1531
2016
Q1
$1.9M Sell
33,700
-22,400
-40% -$1.32M ﹤0.01% 3881
2015
Q4
$3.79M Sell
56,100
-11,400
-17% -$610K ﹤0.01% 2920
2015
Q3
$3.13M Buy
67,500
+57,500
+575% +$2.79M ﹤0.01% 3423
2015
Q2
$538K Buy
+10,000
New +$509K ﹤0.01% 7492

Other funds holding NVRO

Susquehanna International Group's NVRO Position: Q2 2025 in Review

Susquehanna International Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 76,479 shares — an estimated $447K sold.

Susquehanna International Group first reported a position in NVRO in Q4 2014 and held it in 30 quarters. The position peaked at $5.19M in Q1 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Susquehanna International Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 76,479 NEVRO CORP. shares in Q2 2025, an estimated $447K.
  • Susquehanna International Group first reported a position in NEVRO CORP. in Q4 2014 and held it in 30 quarters.
  • Susquehanna International Group's NEVRO CORP. position peaked at $5.19M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.